Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves’ Disease

Table 1

Main characteristics of patients with GD included in this study.

	BT	AT	Range
Number	36	21
Gender (M/F)	9/27	4/17
Age (years)	36.33 ± 14.08	36.83 ± 14.08
T3 (nmol/L)	3.36 ± 2.70	2.15 ± 0.78	1.02-2.96
T4 (nmol/L)	155.43 ± 91.10	113.99 ± 26.25	55.47-161.25
FT3 (pmol/L)	11.13 ± 8.70	4.24 ± 0.47	2.77-6.31
FT4 (pmol/L)	29.01 ± 25.56	15.01 ± 5.23	10.45-24.38
TSH (mIU/L)	0.032 ± 0.040	1.809 ± 1.534	0.380-4.340
Tg-Ab (U/mL)	207.49 ± 242.63	65.46 ± 48.52	<60
TPO-Ab (IU/mL)	1225.67 ± 1275.55	711.59 ± 1237.49	<100

Note: data are presented as deviation. M/F: male/female; BT: before treatment with new diagnosis; AT: after treatment; TSH: thyroid-stimulating hormone; T3: triiodothyronine; T4: thyroxine; FT3: free T3; FT4: free T4; Tg-Ab: thyroglobulin antibody; TPO-Ab: thyroperoxidase antibody.